Want to see AU:NOX full AI Analyst Report?
Total Valuation
Noxopharm Ltd. has a market cap or net worth of AU$18.74M. The enterprise value is AU$30.46M.
Market CapAU$18.74M
Enterprise ValueAU$30.46M
Share Statistics
Noxopharm Ltd. has 307,237,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding307,237,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Noxopharm Ltd.’s return on equity (ROE) is 1.22 and return on invested capital (ROIC) is -387.14%.
Return on Equity (ROE)1.22
Return on Assets (ROA)-2.43
Return on Invested Capital (ROIC)-387.14%
Return on Capital Employed (ROCE)1.34
Revenue Per Employee178.42K
Profits Per Employee-556.98K
Employee Count8
Asset Turnover0.78
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Noxopharm Ltd. is ―. Noxopharm Ltd.’s PEG ratio is 0.57.
PE Ratio―
PS Ratio18.11
PB Ratio-7.08
Price to FCF-9.53
Price to Operating Cash Flow-6.53
PEG Ratio0.57
Income Statement
In the last 12 months, Noxopharm Ltd. had revenue of 1.43M and earned -4.46M in profits. Earnings per share was -0.01.
Revenue1.43M
Gross Profit-1.74K
Operating Income-4.85M
Pretax Income-5.88M
Net Income-4.46M
EBITDA-3.40M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.71M and capital expenditures 1.86K, giving a free cash flow of -2.71M billion.
Operating Cash Flow-2.71M
Free Cash Flow-2.71M
Free Cash Flow per Share>-0.01
Dividends & Yields
Noxopharm Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.29
52-Week Price Change-41.90%
50-Day Moving Average0.07
200-Day Moving Average0.07
Relative Strength Index (RSI)38.11
Average Volume (3m)81.92K
Important Dates
Noxopharm Ltd. upcoming earnings date is Mar 2, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateMar 2, 2027
Ex-Dividend Date―
Financial Position
Noxopharm Ltd. as a current ratio of 0.34, with Debt / Equity ratio of -125.38%
Current Ratio0.34
Quick Ratio0.34
Debt to Market Cap0.18
Net Debt to EBITDA-1.26
Interest Coverage Ratio-4.18
Taxes
In the past 12 months, Noxopharm Ltd. has paid -1.43M in taxes.
Income Tax-1.43M
Effective Tax Rate0.24
Enterprise Valuation
Noxopharm Ltd. EV to EBITDA ratio is -8.87, with an EV/FCF ratio of -11.10.
EV to Sales21.10
EV to EBITDA-8.87
EV to Free Cash Flow-11.10
EV to Operating Cash Flow-11.10
Balance Sheet
Noxopharm Ltd. has AU$293.57K in cash and marketable securities with AU$4.57M in debt, giving a net cash position of -AU$4.28M billion.
Cash & Marketable SecuritiesAU$293.57K
Total DebtAU$4.57M
Net Cash-AU$4.28M
Net Cash Per Share-AU$0.01
Tangible Book Value Per Share-AU$0.01
Margins
Gross margin is 0.00%, with operating margin of -339.60%, and net profit margin of -312.17%.
Gross Margin0.00%
Operating Margin-339.60%
Pretax Margin-412.17%
Net Profit Margin-312.17%
EBITDA Margin-237.94%
EBIT Margin-238.06%
Analyst Forecast
The average price target for Noxopharm Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast10.18%